Diabetes drug tested to protect hearts after attack
NCT ID NCT05050500
Summary
This study tested whether adding the diabetes drug dapagliflozin improves short-term health for people with type 2 diabetes who recently had a heart attack. It involved 143 participants who were randomly assigned to receive either dapagliflozin or a placebo. Researchers measured heart-related complications, inflammation levels, and survival to see if the drug offered extra protection beyond standard care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mengmei Li
Qingdao, Shandong, 266042, China
Conditions
Explore the condition pages connected to this study.